title: An estrogen receptor repressor induces cataract formation in transgenic mice.
abstract: Despite the high prevalence of age-related cataracts, there are currently no known therapies to delay or prevent their occurrence. Studies in humans and rodent models suggest that estrogen may provide protection against age-related cataracts. The discovery of ocular estrogen receptors (ERs) indicates that estrogen protection may result from direct interactions with its receptors in the eye, instead an indirect consequence from effects on another tissue. Studies in our transgenic mouse model validate the concept that estrogen is beneficial for the eye. These mice express ER Delta , a dominant-negative form of ER alpha that inhibits ER alpha function. In the ER Delta 3 transgenic mice, cortical cataracts spontaneously form in ER Delta 3 females after puberty and progress with age. The cataracts initiate in the equatorial region of the lens where the epithelial cells differentiate into elongating fiber cells. Cataract formation can be prevented if the females are ovariectomized before, but not after, sexual maturity. Both male and female ER Delta 3 mice develop cataracts after neonatal treatment with the potent estrogen diethylstilbestrol (DES). The incidence of spontaneous and DES-induced cataracts in ER Delta 3 mice is 100%, yet these cataracts are absent from the wild-type mice. These data suggest that repression of estrogen action induces cortical cataract formation because estrogen is required to activate the ER Delta 3 repressor. Evidence of DES-induced cataracts in the ER Delta 3 males as well as the females suggests that estrogen is important in lens physiology in both sexes. The ER Delta 3 mice provide a powerful model for assessing the role of estrogen in maintaining the transparency of the lens.
authors.affiliation: Receptor Biology Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA. vicki.davis@cshs.org
authors.forename: Vicki L
authors.initials: VL
authors.lastname: Davis
authors.forename: Chi-Chao
authors.initials: CC
authors.lastname: Chan
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Schoen
authors.forename: John F
authors.initials: JF
authors.lastname: Couse
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Chader
authors.forename: Kenneth S
authors.initials: KS
authors.lastname: Korach
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002386:Cataract / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D004054:Diethylstilbestrol / Q000633:toxicity; D047628:Estrogen Receptor alpha; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D010052:Ovariectomy; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors* / Q000235:genetics; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D012741:Sexual Maturation
chemical_list: D047628:Estrogen Receptor alpha; D011960:Receptors, Estrogen; D012097:Repressor Proteins; D004054:Diethylstilbestrol